# Chugai Z Score

CHGCF -  USA Stock

## USD 33.220.902.78%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Chugai Pharmaceutical Piotroski F Score and Chugai Pharmaceutical Valuation analysis.

## Chugai Z Score Analysis

Chugai Pharmaceutical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 Z Score = Sum Of 5 Factors
More About Z Score | All Equity Analysis

### Current Chugai Pharmaceutical Z Score

1.0
Most of Chugai Pharmaceutical's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
 Compare to competition Predict Chugai Pharmaceutical
In accordance with the company's disclosures, Chugai Pharmaceutical has a Z Score of 1.0. This is 85.19% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturersâ€”General industry. The z score for all United States stocks is 88.53% higher than that of the company.

## Chugai Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chugai Pharmaceutical's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Chugai Pharmaceutical could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics of similar companies.
Chugai Pharmaceutical is currently under evaluation in z score category among related companies.

## Chugai Fundamentals

 Return On Equity 25.44 % Return On Asset 17.91 % Profit Margin 28.88 % Operating Margin 40.18 % Current Valuation (343.51 B) Shares Outstanding 1.64 B Shares Owned by Insiders 60.17 % Shares Owned by Institutions 18.12 % Price to Earning 24.57 X Price to Book 0.05 X Price to Sales 0.06 X Revenue 887.92 B Gross Profit 513.48 B EBITDA 388.02 B Net Income 256.46 B Cash and Equivalents 396.65 B Cash per Share 241.23 X Debt to Equity 0.011 % Current Ratio 3.73 X Book Value Per Share 663.31 X Cash Flow from Operations 256.89 B Earnings Per Share 1.35 X Price to Earnings To Growth 3.86 X Number of Employees 7.55 K Beta 0.65 Market Capitalization 55.25 B Total Asset 769.86 B Retained Earnings 500.19 B Working Capital 435.19 B Current Asset 542.89 B Current Liabilities 107.7 B Z Score 1.0 Last Dividend Paid 0.52

## About Chugai Pharmaceutical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chugai Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chugai Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chugai Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7555 people.

## Chugai Pharmaceutical Investors Sentiment

The influence of Chugai Pharmaceutical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chugai. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chugai Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chugai Pharmaceutical's short interest history, or implied volatility extrapolated from Chugai Pharmaceutical options trading.

## Current Sentiment - CHGCF

### Chugai Pharmaceutical Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Chugai Pharmaceutical. What is your opinion about investing in Chugai Pharmaceutical? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
 Skip

## Pair Trading with Chugai Pharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chugai Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

## Chugai Pharmaceutical Pair Correlation

Correlation analysis and pair trading evaluation for Chugai Pharmaceutical and Johnson Johnson. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
 Run Pair Correlation
Continue to Chugai Pharmaceutical Piotroski F Score and Chugai Pharmaceutical Valuation analysis. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

## Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
 Equity ValuationCheck real value of public entities based on technical and fundamental data Go Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios Go Fundamental AnalysisView fundamental data based on most recent published financial statements Go Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. Go Volatility AnalysisGet historical volatility and risk analysis based on latest market data Go Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins Go Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes Go Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk Go Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated Go Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators Go Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. Go Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets Go Bond DirectoryFind actively traded corporate debentures issued by US companies Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.